Boston Scientific Target Price

See Boston Scientific's analyst price targets ($73) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$50.46

Average Target Price

$72.63

43.9% upside

43 analysts in the last 4 months

High: $100 | Low: $50

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-30	UBS	$67	32.8% upside
2026-07-30	Leerink Partners	$60	18.9% upside
2026-07-30	Canaccord Genuity	$66	30.8% upside
2026-07-30	RBC CapitalShagun Singh	$70	38.7% upside
2026-07-30	Wells Fargo	$50	0.9% downside
2026-07-30	Deutsche BankPito Chickering	$60	18.9% upside
2026-07-30	Raymond JamesJayson Bedford	$57	13% upside
2026-07-30	Robert W. Baird	$56	11% upside
2026-07-29	Stifel NicolausRick Wise	$60	18.9% upside
2026-07-29	BTIGMarie Thibault	$60	18.9% upside
2026-07-28	UBS	$74	46.7% upside
2026-07-27	Oppenheimer	$85	68.5% upside
2026-07-16	Truist Financial	$62	22.9% upside
2026-07-15	Mizuho SecuritiesAnthony Petrone	$70	38.7% upside
2026-07-13	RBC CapitalShagun Singh	$85	68.5% upside
2026-07-08	NeedhamMike Matson	$57	13% upside
2026-07-06	Evercore ISI	$65	28.8% upside
2026-06-25	Stifel Nicolaus	$65	28.8% upside
2026-06-12	Piper Sandler	$65	28.8% upside
2026-06-04	Truist Financial	$64	26.8% upside
2026-06-02	BTIGMarie Thibault	$65	28.8% upside
2026-06-01	Canaccord Genuity	$70	38.7% upside
2026-05-28	Goldman Sachs	$71	40.7% upside
2026-05-28	Robert W. Baird	$70	38.7% upside
2026-05-28	Wells FargoLarry Biegelsen	$55	9% upside
2026-05-28	Barclays	$89	76.4% upside
2026-05-28	Leerink PartnersMike Kratky	$74	46.7% upside
2026-05-27	Stifel NicolausRick Wise	$75	48.6% upside
2026-05-19	Robert W. Baird	$75	48.6% upside
2026-04-29	Daiwa	$60	18.9% upside
2026-04-23	RBC Capital	$100	98.2% upside
2026-04-23	Robert W. Baird	$78	54.6% upside
2026-04-23	Wells Fargo	$75	48.6% upside
2026-04-23	Canaccord GenuityWilliam Plovanic	$71	40.7% upside
2026-04-23	Truist Financial	$85	68.5% upside
2026-04-23	NeedhamMike Matson	$77	52.6% upside
2026-04-23	Oppenheimer	$90	78.4% upside
2026-04-23	BarclaysMatt Miksic	$96	90.2% upside
2026-04-22	JefferiesMatthew Taylor	$100	98.2% upside
2026-04-22	Goldman SachsDavid Roman	$84	66.5% upside
2026-04-21	Stifel NicolausRick Wise	$85	68.5% upside
2026-04-15	Truist Financial	$90	78.4% upside
2026-04-13	Mizuho Securities	$90	78.4% upside
2026-03-26	Goldman Sachs	$93	84.3% upside
2026-02-17	Canaccord GenuityWilliam Plovanic	$109	116% upside
2026-02-06	BernsteinLee Hambright	$112	122% upside
2026-02-05	Mizuho Securities	$115	127.9% upside
2026-02-05	Needham	$97	92.2% upside
2026-02-05	RBC Capital	$115	127.9% upside
2026-02-05	Truist Financial	$95	88.3% upside

Boston Scientific (BSX) FAQ

Boston Scientific's target price stands at $73. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $73 for BSX implies 43.9% upside versus today's price ($50.46). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Boston Scientific's target price evolved across reporting periods, while the comparison chart places BSX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Boston Scientific's reading of $73 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.